ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of May 20, 2026, ZTS trades at $80.12 with a market cap of $32.58B and a P/E ratio of 13.29. ZTS moved +0.87% today. Year to date, ZTS is -37.33%; over the trailing twelve months it is -51.86%. Its 52-week range spans $72.38 to $197.51. Analyst consensus is buy with an average price target of $129.29. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ZTS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZTS recently traded at $80.12. Market cap is $32.58B. P/E ratio is 13.29. Revenue is $9.51B.
| Metric | Value |
|---|---|
| Price | $80.12 |
| Market Cap | $32.58B |
| P/E Ratio | 13.29 |
| EPS | $6.04 |
| Dividend Yield | 0.53% |
| 52-Week High | $197.51 |
| 52-Week Low | $72.38 |
| Volume | 5.99M |
| Avg Volume | 0 |
| Revenue (TTM) | $9.51B |
| Net Income | $2.64B |
| Gross Margin | 71.76% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $9.26B | $2.50B | $5.47 |
| 2023 | $8.54B | $2.34B | $5.08 |
| 2022 | $8.08B | $2.11B | $4.51 |
| 2021 | $7.78B | $2.03B | $4.29 |
14 analysts cover ZTS: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $129.29.